TGF-beta1 WNT and SHH signaling in tumor progression and in fibrotic diseases
Frontiers in Bioscience · 2017 · 9 (1) · 31-45
DOI: 10.2741/s470 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience, 2017. Verfasst von Maria D Castellone und 1 weiteren Autor:innen. Beteiligte Einrichtung: IEOS-CNR, Via Pansini 5, 80014 Naples, Italy, and Dipartimento di Medicina Molecolare e Biotecnologie mediche, University of Naples Federico II, Via …. Die Arbeit wurde bisher 31-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- IEOS-CNR, Via Pansini 5, 80014 Naples, Italy, and Dipartimento di Medicina Molecolare e Biotecnologie mediche, University of Naples Federico II, Via Pansini 5, 80014 Naples, Italy.
- IRCCS SDN, Via E. Gianturco, 801431 Naples, Italy, mlaukkanen@sdn-napoli.it.
Zitieren
APA
Castellone, M. D., & Laukkanen, M. O. (2017). TGF-beta1 WNT and SHH signaling in tumor progression and in fibrotic diseases. Frontiers in Bioscience, 9(1), 31-45. https://doi.org/10.2741/s470
Vancouver
Castellone MD, Laukkanen MO. TGF-beta1 WNT and SHH signaling in tumor progression and in fibrotic diseases. Frontiers in Bioscience. 2017;9(1):31-45. doi:10.2741/s470
BibTeX
@article{Castellone2017,
author = {Castellone, Maria D and Laukkanen, Mikko O},
title = {TGF-beta1 WNT and SHH signaling in tumor progression and in fibrotic diseases},
journal = {Frontiers in Bioscience},
year = {2017},
volume = {9},
number = {1},
pages = {31--45},
doi = {10.2741/s470}
}
EUVIMED